Literature DB >> 20177074

Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase.

Claudia Perrera1, Riccardo Colombo, Barbara Valsasina, Patrizia Carpinelli, Sonia Troiani, Michele Modugno, Laura Gianellini, Paolo Cappella, Antonella Isacchi, Jurgen Moll, Luisa Rusconi.   

Abstract

Aurora kinases are mitotic enzymes involved in centrosome maturation and separation, spindle assembly and stability, and chromosome condensation, segregation, and cytokinesis and represent well known targets for cancer therapy because their deregulation has been linked to tumorigenesis. The availability of suitable markers is of crucial importance to investigate the functions of Auroras and monitor kinase inhibition in in vivo models and in clinical trials. Extending the knowledge on Aurora substrates could help to better understand their biology and could be a source for clinical biomarkers. Using biochemical, mass spectrometric, and cellular approaches, we identified MYBBP1A as a novel Aurora B substrate and serine 1303 as the major phosphorylation site. MYBBP1A is phosphorylated in nocodazole-arrested cells and is dephosphorylated upon Aurora B silencing or by treatment with Danusertib, a small molecule inhibitor of Aurora kinases. Furthermore, we show that MYBBP1A depletion by RNA interference causes mitotic progression delay and spindle assembly defects. MYBBP1A has until now been described as a nucleolar protein, mainly involved in transcriptional regulation. The results presented herein show MYBBP1A as a novel Aurora B kinase substrate and reveal a not yet recognized link of this nucleolar protein to mitosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20177074      PMCID: PMC2852913          DOI: 10.1074/jbc.M109.068312

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

1.  Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells.

Authors:  Toru Hirota; Naoko Kunitoku; Takashi Sasayama; Tomotoshi Marumoto; Dongwei Zhang; Masayuki Nitta; Katsuyoshi Hatakeyama; Hideyuki Saya
Journal:  Cell       Date:  2003-09-05       Impact factor: 41.582

2.  Large-scale characterization of HeLa cell nuclear phosphoproteins.

Authors:  Sean A Beausoleil; Mark Jedrychowski; Daniel Schwartz; Joshua E Elias; Judit Villén; Jiaxu Li; Martin A Cohn; Lewis C Cantley; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

3.  BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition.

Authors:  Mutsuko Ouchi; Nobuko Fujiuchi; Kaori Sasai; Hiroshi Katayama; Yohji A Minamishima; Pat P Ongusaha; Chuxia Deng; Subrata Sen; Sam W Lee; Toru Ouchi
Journal:  J Biol Chem       Date:  2004-02-27       Impact factor: 5.157

4.  Distribution of c-myc, c-myb, and Ki-67 antigens in interphase and mitotic human cells evidenced by immunofluorescence staining technique.

Authors:  H Bading; E W Rauterberg; K Moelling
Journal:  Exp Cell Res       Date:  1989-11       Impact factor: 3.905

5.  Nucleolar proteome dynamics.

Authors:  Jens S Andersen; Yun W Lam; Anthony K L Leung; Shao-En Ong; Carol E Lyon; Angus I Lamond; Matthias Mann
Journal:  Nature       Date:  2005-01-06       Impact factor: 49.962

6.  An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.

Authors:  G Anfossi; A M Gewirtz; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Identification of 315 genes essential for early zebrafish development.

Authors:  Adam Amsterdam; Robert M Nissen; Zhaoxia Sun; Eric C Swindell; Sarah Farrington; Nancy Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

8.  Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition.

Authors:  Stéphanie Dutertre; Martine Cazales; Muriel Quaranta; Carine Froment; Valerie Trabut; Christine Dozier; Gladys Mirey; Jean-Pierre Bouché; Nathalie Theis-Febvre; Estelle Schmitt; Bernard Monsarrat; Claude Prigent; Bernard Ducommun
Journal:  J Cell Sci       Date:  2004-05-05       Impact factor: 5.285

9.  Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK.

Authors:  Melina Fan; James Rhee; Julie St-Pierre; Christoph Handschin; Pere Puigserver; Jiandie Lin; Sibylle Jäeger; Hediye Erdjument-Bromage; Paul Tempst; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2004-01-26       Impact factor: 11.361

10.  Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle.

Authors:  Reto Gassmann; Ana Carvalho; Alexander J Henzing; Sandrine Ruchaud; Damien F Hudson; Reiko Honda; Erich A Nigg; Dietlind L Gerloff; William C Earnshaw
Journal:  J Cell Biol       Date:  2004-07-12       Impact factor: 10.539

View more
  12 in total

1.  Myb-binding protein 1a (Mybbp1a) regulates levels and processing of pre-ribosomal RNA.

Authors:  Julia Hochstatter; Michael Hölzel; Michaela Rohrmoser; Lothar Schermelleh; Heinrich Leonhardt; Rebecca Keough; Thomas J Gonda; Axel Imhof; Dirk Eick; Gernot Längst; Attila Németh
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

Review 2.  The protein-interaction network with functional roles in tumorigenesis, neurodegeneration, and aging.

Authors:  Jarmila Nahálková
Journal:  Mol Cell Biochem       Date:  2016-10-03       Impact factor: 3.396

3.  Development of a chemical genetic approach for human aurora B kinase identifies novel substrates of the chromosomal passenger complex.

Authors:  Rutger C C Hengeveld; Nicholas T Hertz; Martijn J M Vromans; Chao Zhang; Alma L Burlingame; Kevan M Shokat; Susanne M A Lens
Journal:  Mol Cell Proteomics       Date:  2012-01-20       Impact factor: 5.911

4.  Epigenetic silencing of myogenic gene program by Myb-binding protein 1a suppresses myogenesis.

Authors:  Chang-Ching Yang; Hsuan Liu; Shen Liang Chen; Tzu-Hao Wang; Chia-Ling Hsieh; Yi Huang; Shu-Jen Chen; Hua-Chien Chen; Benjamin Yat-Ming Yung; Bertrand Chin-Ming Tan
Journal:  EMBO J       Date:  2012-02-14       Impact factor: 11.598

Review 5.  WSTF does it all: a multifunctional protein in transcription, repair, and replication.

Authors:  Chris Barnett; Jocelyn E Krebs
Journal:  Biochem Cell Biol       Date:  2011-02       Impact factor: 3.626

6.  Myb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressor.

Authors:  Silvia Mori; Rosa Bernardi; Audrey Laurent; Massimo Resnati; Ambra Crippa; Arianna Gabrieli; Rebecca Keough; Thomas J Gonda; Francesco Blasi
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

7.  Opposing function of MYBBP1A in proliferation and migration of head and neck squamous cell carcinoma cells.

Authors:  Gustavo A Acuña Sanhueza; Leonie Faller; Babitha George; Jennifer Koffler; Vinko Misetic; Christa Flechtenmacher; Gerhard Dyckhoff; Peter P Plinkert; Peter Angel; Christian Simon; Jochen Hess
Journal:  BMC Cancer       Date:  2012-02-17       Impact factor: 4.430

8.  Epigeneitc silencing of ribosomal RNA genes by Mybbp1a.

Authors:  Bertrand Chin-Ming Tan; Chang-Ching Yang; Chia-Ling Hsieh; Yin-Hsiang Chou; Chang-Zheng Zhong; Benjamin Yat-Ming Yung; Hsuan Liu
Journal:  J Biomed Sci       Date:  2012-06-11       Impact factor: 8.410

9.  p38-MAPK-mediated translation regulation during early blastocyst development is required for primitive endoderm differentiation in mice.

Authors:  Pablo Bora; Lenka Gahurova; Tomáš Mašek; Andrea Hauserova; David Potěšil; Denisa Jansova; Andrej Susor; Zbyněk Zdráhal; Anna Ajduk; Martin Pospíšek; Alexander W Bruce
Journal:  Commun Biol       Date:  2021-06-25

10.  The transcription factor YY1 is a novel substrate for Aurora B kinase at G2/M transition of the cell cycle.

Authors:  Ari Kassardjian; Raed Rizkallah; Sarah Riman; Samuel H Renfro; Karen E Alexander; Myra M Hurt
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.